These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18049924)

  • 1. A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness.
    Geier DA; Sykes LK; Geier MR
    J Toxicol Environ Health B Crit Rev; 2007 Dec; 10(8):575-96. PubMed ID: 18049924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations regarding the use of vaccines that contain thimerosal as a preservative.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Nov; 48(43):996-8. PubMed ID: 10577494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(26):563-5. PubMed ID: 10418806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines.
    Dórea JG; Marques RC
    Toxicol Sci; 2008 Jun; 103(2):414-5; author reply 416. PubMed ID: 18364366
    [No Abstract]   [Full Text] [Related]  

  • 5. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
    Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
    N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of thimerosal use in childhood vaccines.
    Ball LK; Ball R; Pratt RD
    Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
    Parker SK; Schwartz B; Todd J; Pickering LK
    Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
    Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F
    Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
    Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J
    Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
    Ann Pharmacother; 1999 Sep; 33(9):1021. PubMed ID: 10492513
    [No Abstract]   [Full Text] [Related]  

  • 11. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
    Rooney JP
    Pediatrics; 2008 Oct; 122(4):902; author reply 902-3. PubMed ID: 18829819
    [No Abstract]   [Full Text] [Related]  

  • 12. Of vaccine-autism, thimerosal, and metallothioneins.
    Guzzi G
    Pediatr Allergy Immunol; 2007 Feb; 18(1):88; author reply 89. PubMed ID: 17295805
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mercury in vaccines].
    Hessel L
    Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thimerosal and vaccines--a cautionary tale.
    Offit PA
    N Engl J Med; 2007 Sep; 357(13):1278-9. PubMed ID: 17898096
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants.
    Magos L
    J Appl Toxicol; 2003; 23(4):263-9. PubMed ID: 12884410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States.
    Geier DA; Geier MR
    J Toxicol Environ Health A; 2006 Aug; 69(15):1481-95. PubMed ID: 16766480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ; McIntyre PB
    Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mercury rising: warnings in pregnancy & infancy.
    Ohm J
    Midwifery Today Int Midwife; 2005; (74):46-7, 68. PubMed ID: 16022361
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of mercury in the pathogenesis of autism.
    Bernard S; Enayati A; Roger H; Binstock T; Redwood L
    Mol Psychiatry; 2002; 7 Suppl 2():S42-3. PubMed ID: 12142947
    [No Abstract]   [Full Text] [Related]  

  • 20. The evidence for the safety of thiomersal in newborn and infant vaccines.
    Clements CJ
    Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.